We are live on ! Find out more
Marshall Wace

Marshall Wace Portfolio holdings

AUM $100B
1-Year Est. Return 35.1%
This Fund
S&P 500
This Quarter Est. Return
-3.14%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$52.8B
AUM Growth
-$1.34B
Cap. Flow
+$1.39B
Cap. Flow %
2.62%
Top 10 Hldgs %
12%
Holding
4,607
New
780
Increased
956
Reduced
789
Closed
1,336

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$532M
2
WFC icon
Wells Fargo
WFC
+$480M
3
V icon
Visa
V
+$435M
4
VZ icon
Verizon
VZ
+$320M
5
AVGO icon
Broadcom
AVGO
+$273M

Sector Composition

Rank Sector Weight
1 Financials 18.66%
2 Technology 16.35%
3 Healthcare 16.13%
4 Consumer Discretionary 11.2%
5 Industrials 7.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MYGN icon
1951
Myriad Genetics
MYGN
$476M
$2.29M ﹤0.01%
+91,025
New +$2.33M
LFLYW
1952
CALL
DELISTED
Leafly Holdings, Inc. Warrant
LFLYW
$2.29M ﹤0.01%
276,243
+31,195
+13% +$26K
SSAAW
1953
CALL
DELISTED
Science Strategic Acquisition Corp. Alpha Warrant
SSAAW
$2.29M ﹤0.01%
233,221
WMK icon
1954
Weis Markets
WMK
$1.93B
$2.29M ﹤0.01%
31,986
+7,325
+30% +$486K
EPWR.WS
1955
CALL
DELISTED
Empowerment & Inclusion Capital I Corp. Redeemable warrants, each whole warrant exercisable for one share of Class A common stock, each at an exercise price of $11.50 per share
EPWR.WS
$2.28M ﹤0.01%
232,211
ASTL icon
1956
Algoma Steel
ASTL
$449M
$2.28M ﹤0.01%
202,430
-263,567
-57% -$2.6M
CITEW
1957
CALL
DELISTED
Cartica Acquisition Corp Warrant
CITEW
$2.28M ﹤0.01%
+227,414
New +$58.2K
HR icon
1958
Healthcare Realty
HR
$7.55B
$2.27M ﹤0.01%
72,584
+52,578
+263% +$1.66M
VLAT
1959
DELISTED
Valor Latitude Acquisition Corp. Class A Ordinary Shares
VLAT
$2.26M ﹤0.01%
232,672
UPLD icon
1960
Upland Software
UPLD
$13.6M
$2.25M ﹤0.01%
12,786
-16,348
-56% -$3M
UTAAW
1961
CALL
DELISTED
UTA Acquisition Corporation Warrants
UTAAW
$2.25M ﹤0.01%
+224,999
New +$83.4K
TAL icon
1962
TAL Education Group
TAL
$6.04B
$2.25M ﹤0.01%
746,705
-460,888
-38% -$1.42M
ADBE icon
1963
CALL
Adobe
ADBE
$105B
$2.23M ﹤0.01%
4,900
+4,500
+1,125% +$2.16M
CAMT icon
1964
Camtek
CAMT
$5.92B
$2.23M ﹤0.01%
73,242
+68,760
+1,534% +$2.42M
CFB
1965
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$2.23M ﹤0.01%
141,281
-2,076
-1% -$32.9K
MAQC
1966
DELISTED
Maquia Capital Acquisition Corporation Class A Common Stock
MAQC
$2.23M ﹤0.01%
219,715
EACPW
1967
CALL
DELISTED
Edify Acquisition Corp. Warrant
EACPW
$2.21M ﹤0.01%
224,994
IBER.WS
1968
CALL
DELISTED
Ibere Pharmaceuticals Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50 per share
IBER.WS
$2.21M ﹤0.01%
224,997
G icon
1969
Genpact
G
$6.22B
$2.21M ﹤0.01%
+50,701
New +$2.35M
NRDY.WS
1970
CALL
DELISTED
Nerdy Inc. Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50 per share
NRDY.WS
$2.21M ﹤0.01%
433,306
WQGA.WS
1971
CALL
DELISTED
World Quantum Growth Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
WQGA.WS
$2.21M ﹤0.01%
222,881
CVIIW
1972
CALL
DELISTED
Churchill Capital Corp VII Warrants
CVIIW
$2.2M ﹤0.01%
224,261
FMIVW
1973
CALL
DELISTED
Forum Merger IV Corporation Warrant
FMIVW
$2.2M ﹤0.01%
224,995
KLRS
1974
Kalaris Therapeutics
KLRS
$80.4M
$2.19M ﹤0.01%
14,116
-131
-0.9% -$26.1K
VRN
1975
DELISTED
Veren
VRN
$2.19M ﹤0.01%
302,228
-34,461
-10% -$233K

Similar funds

Marshall Wace's Q1 2022 Portfolio in Review

As of Q1 2022, Marshall Wace held 4,607 positions worth $52.8B, down 2.5% from $54.2B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Marshall Wace's Q1 2022 filing shows 780 new, 956 increased, 789 reduced and 1,336 closed positions. Its largest new stake was Agilent Technologies: 1,082,487 shares worth $143M. The largest sale was Microsoft, an estimated $547M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 16% a quarter earlier, followed by Technology and Healthcare.

  • Marshall Wace's largest Q1 2022 buy was Agilent Technologies: 1,082,487 shares worth $143M.
  • Marshall Wace added most to Merck in Q1 2022, an estimated $532M increase.
  • Marshall Wace's biggest Q1 2022 reduction was Microsoft, cutting an estimated $547M.
  • Marshall Wace fully exited Elevance Health in Q1 2022, selling an estimated $226M.
  • Marshall Wace's ten largest holdings make up 12% of its $52.8B portfolio in Q1 2022.
  • Marshall Wace opened 780 new positions and closed 1,336 in Q1 2022.
  • Marshall Wace's portfolio value fell 2.5% quarter-over-quarter to $52.8B.

Based on Marshall Wace's 13F filing for Q1 2022, filed 16 May 2022.